ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
Should systemic thrombolytic therapy be considered a first-line treatment in acute pulmonary embolism? [Anatol J Cardiol]
Anatol J Cardiol. 2015; 15(1): 82-83 | DOI: 10.5152/akd.2014.5861

Should systemic thrombolytic therapy be considered a first-line treatment in acute pulmonary embolism?

Orhan Gökalp1, Yüksel Beşir2, Börtecin Eygi2, Gamze Gökalp3
1Department of Cardiovascular Surgery, Faculty of Medicine, İzmir Katip Çelebi University; İzmir-Turkey
2Department of Cardiovascular Surgery, İzmir Katip Celebi University, Atatürk Education and Research Hospital; İzmir-Turkey
3Department of Pediatric Emergency, Tepecik Education and Research Hospital; İzmir-Turkey


Akut pulmoner emboli tedavisinde sistemik trombolitik tedavi kullanımı ilk tercih mi dir?

Orhan Gökalp1, Yüksel Beşir2, Börtecin Eygi2, Gamze Gökalp3
1Department of Cardiovascular Surgery, Faculty of Medicine, İzmir Katip Çelebi University; İzmir-Turkey
2Department of Cardiovascular Surgery, İzmir Katip Celebi University, Atatürk Education and Research Hospital; İzmir-Turkey
3Department of Pediatric Emergency, Tepecik Education and Research Hospital; İzmir-Turkey


Orhan Gökalp, Yüksel Beşir, Börtecin Eygi, Gamze Gökalp. Should systemic thrombolytic therapy be considered a first-line treatment in acute pulmonary embolism?. Anatol J Cardiol. 2015; 15(1): 82-83
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.